Medical robotics

ReWalk Robotics to Report Fourth Quarter 2020 Financial Results on February 18, 2021

Retrieved on: 
Monday, February 15, 2021

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

Key Points: 
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.

Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference

Retrieved on: 
Tuesday, January 5, 2021

RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President & Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference held January 11 14, 2021.

Key Points: 
  • RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President & Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference held January 11 14, 2021.
  • Ekso Bionicsis a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications.
  • Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe.
  • The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO.

ReWalk Robotics Donates ReStore Exo-Suit to Brooks Rehabilitation to Support Stroke Survivors

Retrieved on: 
Monday, December 21, 2020

Brooks combines highly trained clinicians with the latest technologies to advance rehabilitation through innovation and research-based practices.

Key Points: 
  • Brooks combines highly trained clinicians with the latest technologies to advance rehabilitation through innovation and research-based practices.
  • Thanks to this donation, we are able to offer our patients additional options for their stroke recovery," said Robert McIver, PT, DPT, NCS, Director of Clinical Technology at Brooks Rehabilitation.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • For 50 years, Brooks Rehabilitation, headquartered in Jacksonville, Fla., has been a comprehensive source for physical rehabilitation services.

Robotics Specialist German Bionic Receives US $20 Million in Series A Financing

Retrieved on: 
Monday, December 14, 2020

AUGSBURG, Germany, Dec. 14, 2020 /PRNewswire/ --German Bionic, the global market leader for robotic exoskeletons, today announced it has closed US $20 million in Series A financing.

Key Points: 
  • AUGSBURG, Germany, Dec. 14, 2020 /PRNewswire/ --German Bionic, the global market leader for robotic exoskeletons, today announced it has closed US $20 million in Series A financing.
  • The financing round will enable German Bionic to expand its market and technology leadership for connected exoskeletons as well as ramp up development of its unique cloud robotics platform.
  • Measurable data underscores that this ultimately increases productivity and the efficiency of the work done," says Armin G. Schmidt, CEO of German Bionic.
  • German Bionic is proud to have renowned international technology investors on board for the Series A financing round.

Leading German Private Health Insurer Enters Contract to Provide ReWalk Exoskeletons to Individuals with Spinal Cord Injuries

Retrieved on: 
Thursday, December 10, 2020

The contractual agreement is the first such agreement with a private health insurer and follows a series of contracts with several statutory health insurance companies in Germany, which ReWalk signed earlier this year.

Key Points: 
  • The contractual agreement is the first such agreement with a private health insurer and follows a series of contracts with several statutory health insurance companies in Germany, which ReWalk signed earlier this year.
  • Under the terms of this contract, eligible individuals can receive a ReWalk Personal 6.0 exoskeleton for everyday use after successful training, which can enable individuals with SCIs to stand and walk again.
  • The ready adoption of supply contracts by public and private insurers across Germany supports exoskeleton devices for spinal cord injury becoming a standard of care for qualified beneficiaries, said ReWalk CEO Larry Jasinski.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

ReWalk Robotics Announces Closing of $8.0 Million Private Placement Priced At-the-Market

Retrieved on: 
Tuesday, December 8, 2020

H.C. Wainwright & Co. acted as the sole placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the sole placement agent for the offering.
  • ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStoreis a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.

ReWalk Robotics Announces $8.0 Million Private Placement Priced At-the-Market

Retrieved on: 
Thursday, December 3, 2020

The closing of the private placement is expected to occur on or about December 7, 2020, subject to satisfaction of customary closing conditions.

Key Points: 
  • The closing of the private placement is expected to occur on or about December 7, 2020, subject to satisfaction of customary closing conditions.
  • ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.
  • ReStoreis a registered trademark of ReWalk Robotics Ltd. in Europe and an allowed trademark in the United States.

Sarcos Robotics Named to TIME’s List of 100 Best Inventions of 2020 for its Guardian XO Full-Body, Powered Industrial Exoskeleton

Retrieved on: 
Friday, November 20, 2020

The Guardian XO exoskeleton was selected for this prestigious annual list in the Productivity category, among three other products designed to streamline the way we work.

Key Points: 
  • The Guardian XO exoskeleton was selected for this prestigious annual list in the Productivity category, among three other products designed to streamline the way we work.
  • An earlier hydraulically-powered prototype version of the Guardian XO exoskeleton, the XOS 2, was also named to TIMEs Best Inventions of 2010 list.
  • The Guardian XO exoskeleton is designed to significantly increase the wearer's strength and endurance while eliminating strain and fatigue on the body.
  • We are thrilled and honored to be recognized by TIME once again in their esteemed annual Best Inventions list, said Ben Wolff, chairman and CEO, Sarcos Robotics.

Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company

Retrieved on: 
Tuesday, November 10, 2020

RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, EVO, with a subscription-based order by Cloverdale Foods Company, a fourth generation, family-owned meat company.

Key Points: 
  • RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, EVO, with a subscription-based order by Cloverdale Foods Company, a fourth generation, family-owned meat company.
  • We are proud to help Cloverdale in its commitment to protecting the health of its employees and enhancing overall productivity, said Michael Pratt, Vice President at Ekso Bionics.
  • Cloverdale Foods Company is a fourth generation, family owned meat company based in Mandan, North Dakota.
  • To learn more about Ekso Bionics please visit the Companys website at www.eksobionics.com or refer to the Companys Twitter page at @EksoBionics.

ReWalk Robotics to Present at the H.C. WAINWRIGHT 6th Annual Israel Virtual Conference on November 12th, 2020

Retrieved on: 
Monday, November 9, 2020

and BERLIN and YOKNEAM ILIT, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement will present a fireside chat at the H.C.WAINWRIGHT virtual conference at 01:30 PM EST on Thursday November 12, 2020.

Key Points: 
  • and BERLIN and YOKNEAM ILIT, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (ReWalk or the Company) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan, VP Marketing and Reimbursement will present a fireside chat at the H.C.WAINWRIGHT virtual conference at 01:30 PM EST on Thursday November 12, 2020.
  • ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
  • Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
  • ReWalkis a registered trademark of ReWalk Robotics Ltd. in Israel and the United States.